Last updated on November 2019

A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease


Brief description of study

The purpose of this study is to evaluate the safety and efficacy of a study drug that targets an abnormal protein in the brain found in people with Alzheimer's Disease (AD).

Clinical Study Identifier: NCT03518073

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.